Cargando…

Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage

Runt-related transcription factor 2 (RUNX2) is the best known as an essential protein for osteoblast differentiation. In this study, we have found for the first time that RUNX2 acts as a negative regulator for p53 in response to DNA damage. On DNA damage mediated by adriamycin (ADR) exposure, p53 as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozaki, T, Wu, D, Sugimoto, H, Nagase, H, Nakagawara, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641350/ https://www.ncbi.nlm.nih.gov/pubmed/23618908 http://dx.doi.org/10.1038/cddis.2013.127

Ejemplares similares

RUNX Family Participates in the Regulation of p53-Dependent DNA Damage Response
por: Ozaki, Toshinori, et al.
Publicado: (2013)

Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity
por: Ozaki, Toshinori, et al.
Publicado: (2015)

Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 and TAp63
por: Ogata, Takehiro, et al.
Publicado: (2017)

Effects of runt-related transcription factor 2 (RUNX2) on the autophagy of rapamycin-treated osteoblasts
por: Ren, Cheng, et al.
Publicado: (2022)

Runx2 stimulates neoangiogenesis through the Runt domain in melanoma
por: Cecconi, Daniela, et al.
Publicado: (2019)

Runt‐related transcription factor 1 (Runx1) aggravates pathological cardiac hypertrophy by promoting p53 expression
por: Zhang, Dianhong, et al.
Publicado: (2021)

New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration
por: Deiana, Michela, et al.
Publicado: (2018)

Publisher Correction: Runx2 stimulates neoangiogenesis through the Runt domain in melanoma
por: Cecconi, Daniela, et al.
Publicado: (2020)

Trelagliptin stimulates osteoblastic differentiation by increasing runt-related transcription factor 2 (RUNX2): a therapeutic implication in osteoporosis
por: Shao, Haiyu, et al.
Publicado: (2021)

FNDC5/irisin facilitates muscle−adipose−bone connectivity through ubiquitination-dependent activation of runt-related transcriptional factors RUNX1/2
por: He, Xinyu, et al.
Publicado: (2022)

Hairless is a cofactor for Runt-dependent transcriptional regulation
por: Walrad, Pegine B., et al.
Publicado: (2011)

The NAD-Dependent Deacetylase Sirtuin-1 Regulates the Expression of Osteogenic Transcriptional Activator Runt-Related Transcription Factor 2 (Runx2) and Production of Matrix Metalloproteinase (MMP)-13 in Chondrocytes in Osteoarthritis
por: Terauchi, Koh, et al.
Publicado: (2016)

MiRNA-218 inhibits cell proliferation, migration and invasion by targeting Runt-related transcription factor 2 (Runx2) in human osteosarcoma cells
por: Guo, Qiang, et al.
Publicado: (2021)

Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death
por: Sugimoto, H, et al.
Publicado: (2015)

Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death
por: Sugimoto, H, et al.
Publicado: (2015)

Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer
por: Kayed, H, et al.
Publicado: (2007)

Characterisation of an aptamer against the Runt domain of AML1 (RUNX1) by NMR and mutational analyses
por: Takada, Kenta, et al.
Publicado: (2018)

miR-27b attenuates apoptosis induced by transmissible gastroenteritis virus (TGEV) infection via targeting runt-related transcription factor 1 (RUNX1)
por: Zhao, Xiaomin, et al.
Publicado: (2016)

Runx1t1 (Runt-Related Transcription Factor 1; Translocated to, 1) Epigenetically Regulates the Proliferation and Nitric Oxide Production of Microglia
por: Baby, Nimmi, et al.
Publicado: (2014)

Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death
por: Nakamura, M, et al.
Publicado: (2016)

Saxagliptin enhances osteogenic differentiation in MC3T3-E1 cells, dependent on the activation of AMP-activated protein kinase α (AMPKα)/runt-related transcription factor-2 (Runx-2)
por: Wang, Qiang, et al.
Publicado: (2022)

The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN
por: Ando, Kiyohiro, et al.
Publicado: (2023)

Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity
por: Hesse, Eric, et al.
Publicado: (2010)

A Potential Role of RUNX2- RUNT Domain in Modulating the Expression of Genes Involved in Bone Metastases: An In Vitro Study with Melanoma Cells
por: Deiana, Michela, et al.
Publicado: (2020)

Runt-related transcription factor 1 promotes apoptosis and inhibits neuroblastoma progression in vitro and in vivo
por: Hong, Mei, et al.
Publicado: (2020)

Colonic manifestations of runt disease.
por: Singer, J. B., et al.
Publicado: (1966)

HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms
por: Manzotti, Gloria, et al.
Publicado: (2019)

Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells
por: Huang, Jing, et al.
Publicado: (2019)

The differentially DNA-methylated region responsible for expression of runt-related transcription factor 2
por: WAKITANI, Shoichi, et al.
Publicado: (2016)

Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis
por: Nakanishi, Yutaka, et al.
Publicado: (2011)

Distinct Contributions of Conserved Modules to Runt Transcription Factor Activity
por: Walrad, Pegine B., et al.
Publicado: (2010)

Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2
por: Ozaki, Toshinori, et al.
Publicado: (2015)

Physiologic Mechanical Stress Directly Induces Bone Formation by Activating Glucose Transporter 1 (Glut 1) in Osteoblasts, Inducing Signaling via NAD+-Dependent Deacetylase (Sirtuin 1) and Runt-Related Transcription Factor 2 (Runx2)
por: Somemura, Shu, et al.
Publicado: (2021)

Down-regulation of miR-340-5p promoted osteogenic differentiation through regulation of runt-related transcription factor-2 (RUNX2) in MC3T3-E1 cells
por: Wang, Xiaochen, et al.
Publicado: (2021)

A Systematic Review of the Role of Runt-Related Transcription Factor 1 (RUNX1) in the Pathogenesis of Hematological Malignancies in Patients With Inherited Bone Marrow Failure Syndromes
por: Illango, Janan, et al.
Publicado: (2022)

Regulatory Role of the RUNX2 Transcription Factor in Lung Cancer Apoptosis
por: Bernal, Camila, et al.
Publicado: (2022)

Tumor necrosis factor-related apoptosis-inducing ligand is a novel transcriptional target of runt-related transcription factor 1
por: Yoshida, Tatsushi, et al.
Publicado: (2021)

p53 Deficiency-Dependent Oncogenicity of Runx3
por: Ito, Kosei, et al.
Publicado: (2023)

The Runt domain of AML1 (RUNX1) binds a sequence-conserved RNA motif that mimics a DNA element
por: Fukunaga, Junichi, et al.
Publicado: (2013)

Collaboration of MYC and RUNX2 in lymphoma simulates T‐cell receptor signaling and attenuates p53 pathway activity
por: Hay, Jodie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oeon1tlbb5kad024tv6l81ethk